StonvexLoading…
StonvexStonvexStonvexCore line items from CLBT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $475.68M | $401.20M | $325.11M | $270.65M |
Operating Income | $66.48M | $56.91M | $33.24M | $1.04M |
Net Income | $78.33M | $-283.01M | $-81.10M | $120.81M |
EPS (Diluted) | $0.31 | $-1.35 | $-0.43 | $0.59 |
Total Assets | $938.85M | $690.57M | $532.88M | $403.29M |
Total Liabilities | $454.53M | $354.55M | $498.67M | $329.43M |
Cash & Equivalents | $124.46M | $191.66M | $189.52M | $87.64M |
Free Cash Flow OCF − CapEx | $160.32M | $123.61M | $96.83M | $13.68M |
Shares Outstanding | 248.58M | 234.52M | 203.23M | 193.01M |